Mariano Barbacid

15PUBLICATIONS
50CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 30, 2026
FAK inhibitor and RAF/MEK clamp avutometinib enhance KRAS G12C inhibitor efficacy in preclinical models of non-small cell lung cancer.

|Sep 22, 2026
RAF1 scaffold integrity shapes chemogenetic degradation outcomes in KRAS-driven lung cancer models.

|Jun 01, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

|Dec 02, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou

|Oct 29, 2025
The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies.

Matthias Drosten, Mariano Barbacid

|Aug 18, 2025
Systemic Kras ablation disrupts myeloid cell homeostasis in adult mice.

Elena Zamorano-Dominguez, Lucía Morales-Cacho, Rebeca Barrero

Pageof 3

Frequent Collaborators

10 joint publications

Matthias Drosten

5 joint publications

Carmen Guerra

5 joint publications

Monica Musteanu

4 joint publications

Eduardo Caleiras